dasatinib sun 80 mg tabletki powlekane
sun pharmaceutical industries europe b.v. - dasatinibum - tabletki powlekane - 80 mg
dasatinib sun 140 mg tabletki powlekane
sun pharmaceutical industries europe b.v. - dasatinibum - tabletki powlekane - 140 mg
dasatinib sun 100 mg tabletki powlekane
sun pharmaceutical industries europe b.v. - dasatinibum - tabletki powlekane - 100 mg
dasatinib sun 20 mg tabletki powlekane
sun pharmaceutical industries europe b.v. - dasatinibum - tabletki powlekane - 20 mg
dasatinib sun 50 mg tabletki powlekane
sun pharmaceutical industries europe b.v. - dasatinibum - tabletki powlekane - 50 mg
dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - Środki przeciwnowotworowe - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - Środki przeciwnowotworowe - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
zepatier
merck sharp & dohme b.v. - dziś firma otwiera, rozwija, grazoprevir - wirusowe zapalenie wątroby typu c, przewlekłe - direct acting antivirals, antivirals for systemic use, antivirals for treatment of hcv infections - zepatier is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients 12 years of age and older who weigh at least 30 kg (see sections 4. 2, 4. 4 i 5. wirus zapalenia wątroby typu c (hcv) genotyp-specyficznej aktywności patrz rozdziały 4. 4 i 5.
neo-pancreatinum forte 10000 j.m. lipazy kapsułki dojelitowe
pharmaswiss Česká republika s.r.o. - pancreatinum - kapsułki dojelitowe - 10000 j.m. lipazy
rocuronium mylan 10 mg/ml roztwór do wstrzykiwań lub do infuzji
mylan s.a.s. - rocuronii bromidum - roztwór do wstrzykiwań lub do infuzji - 10 mg/ml